Various bacterial targets

The term "various bacterial targets" refers collectively to *multiple distinct molecular entities present in bacteria that are or could be exploited for antibacterial therapy*. These targets span a wide range of structural and functional classes—enzymes responsible for cell wall synthesis (penicillin-binding proteins, MurA), components of the ribosomal machinery for protein synthesis (30S and 50S rRNA, ribosomal proteins), DNA/RNA metabolic enzymes (gyrase, topoisomerase IV, RNA polymerase), membrane proteins involved in cellular integrity, and essential metabolic pathway enzymes (dihydrofolate reductase, LpxC, etc.)[1][2][4][5]. Identification and validation of such targets is key for drug development, and considerable efforts (including databases like BacFITBase and ARTS-DB) document which bacterial genes/proteins are essential for infection and serve as practical therapeutic targets[3][5]. However, the use of a non-specific collective name, rather than a distinct molecular entity, does not conform to established conventions for therapeutic target annotation. If you need structured information on a specific named bacterial target or class (e.g. "DNA gyrase", "MurA", "Ribosomal 50S subunit"), please provide that name for a precise and structured entry.

Other names

Bacterial targetAntibacterial targetAntimicrobial targetBacterial drug target

Inhibition of cell wall biosynthesis (targeting penicillin-binding proteins, MurA, or other enzymes); Inhibition of protein synthesis (binding ribosomal subunits); Inhibition of nucleic acid synthesis (DNA gyrase, RNA polymerase inhibition); Disruption of membrane integrity; Inhibition of metabolic enzymes (folic acid synthesis, mycolic acid synthesis)